CAN Review Board Roster

Chairperson
Gilbert “Lynn” Marks, M.D. (2020)
Senior Advisor
Tunnell
Cape May, New Jersey

Executive Secretary
Anna L. Ramsey-Ewing, Ph.D.
Director
Office of Grants Management and Scientific Review
National Center for Advancing Translational Sciences
National Institutes of Health
Bethesda, Maryland

Vice Chairperson
Ronald J. Bartek, M.A. (2020)
Co-Founder and Founding President
Friedreich's Ataxia Research Alliance
Arlington, Virginia

Board Members

(Terms end 9/30 of designated year, unless otherwise noted.)       

Daniel L. Hartman, M.D. (2019)
Director of Integrated Development
Global Health Discovery Program
Bill and Melinda Gates Foundation
Seattle, Washington

Richard E. Kuntz, M.D., M.Sc. (2019)
Senior Vice President, Chief Medical and Scientific Officer
Medtronic, Inc.
Minneapolis, Minnesota

Geoffrey Shiu Fei Ling, M.D., Ph.D. (2019)
Professor of Neurology
School of Medicine
Johns Hopkins University
Baltimore, Maryland

Brad Margus (2020)
Chief Executive Officer
Cerevance, Inc.
Boston, Massachusetts

Kalpana M. Merchant, Ph.D. (2020)
President and Chief Scientific Officer
TransThera Consulting Company
Portland, Oregon

Megan O’Boyle (2019)

Principal Investigator
Phelan-McDermid Syndrome Data Network
Arlington, Virginia

Alan Palkowitz, Ph.D. (2019)
Vice President of Discovery Chemistry Research and Technologies
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana

Valerie Montgomery Rice, M.D. (2020)
President and Dean
Professor of Obstetrics and Gynecology and  Reproductive Endocrinology and Infertility
Morehouse School of Medicine
Atlanta, Georgia

Todd B. Sherer, Ph.D. (2020)
Chief Executive Officer
Michael J. Fox Foundation for Parkinson’s Research
New York, New York

Sharon F. Terry, M.A. (2020)
President and Chief Executive Officer
Genetic Alliance
Washington, D.C.

Representative Members

Kiran Reddy, M.D. (2022)
Venture Professor
Praxis Precision Medicines, Inc.
Boston, Massachusetts

Michael Rosenblatt, M.D. (2022)
Chief Medical Officer
Flagship Pioneering
Cambridge, Massachusetts

Elizabeth Stoner, M.D. (2022)
Executive Partner
MPM Capital
New York, New York

Ex Officio Members

National Institutes of Health
Francis S. Collins, M.D., Ph.D.
Director
Bethesda, Maryland

Food and Drug Administration
Norman Sharpless, M.D.
Acting Commissioner
Silver Spring, Maryland

National Science Foundation
Richard Dickinson, Ph.D.
Director
Division of Chemical, Bioengineering, Environmental and Transport Systems
Alexandria, Virginia

Department of Defense
Vacant

Department of Veterans Affairs
Rachel Ramoni, D.M.D., Sc.D.
Chief Research and Development Officer
Office of Research and Development
Washington, D.C.